跳至主要内容
临床试验/NCT06570967
NCT06570967招募中不适用

A Retrospective and Prospective Observational Study of Hyperthyroidism in Children

Shengjing Hospital1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2023年7月18日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
1,000
试验地点
1
主要终点
Remission of hyperthyroidism in children treated with methimazole. Remission is defined as having clinical and biochemical euthyroidism(FT3, FT4 and TSH are normal) without methimazole treatment for at least 12 months.

研究概览

简要总结

This study intends to conduct a retrospective and prospective study on children with hyperthyroidism, and it is a non-intervention study to collect information on diagnosis and treatment and long-term follow-up of children with hyperthyroidism. To investigate the clinical characteristics, treatment effect, side effects and remission of hyperthyroidism in children, to analyze the predictive factors for the effect of antithyroid drug treatment, remission and recurrence after drug withdrawal, and to explore the risk factors related to the occurrence of antithyroid drug-related adverse reactions.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
29 Days 至 14 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Age ≤14 years old
  • Initial diagnosis of hyperthyroidism

排除标准

  • Hyperthyroidism had been treated with medication in other hospitals,
  • History of autoimmune hepatitis, viral hepatitis, hematological diseases, bone marrow or liver transplantation,
  • Patients with incomplete clinical data

结局指标

主要结局

Remission of hyperthyroidism in children treated with methimazole. Remission is defined as having clinical and biochemical euthyroidism(FT3, FT4 and TSH are normal) without methimazole treatment for at least 12 months.

时间窗: 10 years

To analyze the therapeutic effect of methimazole and the predictors of remission of hyperthyroidism after methimazole treatment.

Adverse effects of methimazole in the treatment of hyperthyroidism in children. Adverse effects are defined as having neutropenia (absolute neutrophil count< 1500/µL), liver dysfunction (AST or ALT> 60 IU/L), rash, arthralgia, myalgia, et al.

时间窗: 1 year

Analyze the adverse reaction of methimazole treatment in hyperthyroidism children. Explore the risk factors related to the occurrence of methimazole related adverse reactions.

次要结局

  • Relapse of hyperthyroidism in children treated with methimazole. Relapse was defined as having clinical and biochemical hyperthyroidism (FT3 and FT4 increased and TSH decreased) after discontinuation of methimazole.(10 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shi Tang

Attending Physician

Shengjing Hospital

研究点 (1)

Loading locations...

相似试验